TY  - GEN
AU  - Pautier,Patricia
AU  - Floquet,Anne
AU  - Penel,Nicolas
AU  - Piperno-Neumann,Sophie
AU  - Isambert,Nicolas
AU  - Rey,Annie
AU  - Bompas,Emmanuelle
AU  - Cioffi,Angela
AU  - Delcambre,Corinne
AU  - Cupissol,Didier
AU  - Collin,Françoise
AU  - Blay,Jean-Yves
AU  - Jimenez,Marta
AU  - Duffaud,Florence
TI  - Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study)
SN  - 1549-490X
PY  - 2013///0211
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Deoxycytidine
KW  - analogs & derivatives
KW  - Disease-Free Survival
KW  - Docetaxel
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - France
KW  - epidemiology
KW  - Granulocyte Colony-Stimulating Factor
KW  - Humans
KW  - Leiomyosarcoma
KW  - drug therapy
KW  - Lenograstim
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Neoplasm Recurrence, Local
KW  - Recombinant Proteins
KW  - Taxoids
KW  - Uterine Neoplasms
KW  - Gemcitabine
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1634/theoncologist.2011-0467
ER  -